Management of Gastroesophageal Junction Tumors

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Gastroesophageal junction tumors have been increasing in incidence over time, with most tumors presenting at a locally advanced stage. The treatment plan depends on the stage at diagnosis. PET-CT and endoscopic ultrasound are used to determine clinical stage. Depending on the location of the tumor in the esophagus and stomach, treatment can include chemotherapy with or without radiation, followed by surgery if there is no disease progression. Prognosis is related to stage at diagnosis and response to preoperative treatment. Most surgery for gastroesophageal junction tumors can be performed minimally invasively, which helps decrease postoperative length of stay and morbidity from surgery.

Original languageEnglish (US)
Pages (from-to)265-275
Number of pages11
JournalSurgical Clinics of North America
Volume97
Issue number2
DOIs
StatePublished - Apr 1 2017

Fingerprint

Esophagogastric Junction
Neoplasms
Esophagus
Disease Progression
Length of Stay
Stomach
Therapeutics
Radiation
Morbidity
Drug Therapy
Incidence

Keywords

  • Adenocarcinoma
  • Barrett
  • Minimally invasive
  • Neoadjuvant

ASJC Scopus subject areas

  • Surgery
  • Medicine(all)

Cite this

Management of Gastroesophageal Junction Tumors. / Okereke, Ikenna.

In: Surgical Clinics of North America, Vol. 97, No. 2, 01.04.2017, p. 265-275.

Research output: Contribution to journalReview article

@article{8f8c9737a26b40579c2d0d109b04329f,
title = "Management of Gastroesophageal Junction Tumors",
abstract = "Gastroesophageal junction tumors have been increasing in incidence over time, with most tumors presenting at a locally advanced stage. The treatment plan depends on the stage at diagnosis. PET-CT and endoscopic ultrasound are used to determine clinical stage. Depending on the location of the tumor in the esophagus and stomach, treatment can include chemotherapy with or without radiation, followed by surgery if there is no disease progression. Prognosis is related to stage at diagnosis and response to preoperative treatment. Most surgery for gastroesophageal junction tumors can be performed minimally invasively, which helps decrease postoperative length of stay and morbidity from surgery.",
keywords = "Adenocarcinoma, Barrett, Minimally invasive, Neoadjuvant",
author = "Ikenna Okereke",
year = "2017",
month = "4",
day = "1",
doi = "10.1016/j.suc.2016.11.004",
language = "English (US)",
volume = "97",
pages = "265--275",
journal = "Surgical Clinics of North America",
issn = "0039-6109",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Management of Gastroesophageal Junction Tumors

AU - Okereke, Ikenna

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Gastroesophageal junction tumors have been increasing in incidence over time, with most tumors presenting at a locally advanced stage. The treatment plan depends on the stage at diagnosis. PET-CT and endoscopic ultrasound are used to determine clinical stage. Depending on the location of the tumor in the esophagus and stomach, treatment can include chemotherapy with or without radiation, followed by surgery if there is no disease progression. Prognosis is related to stage at diagnosis and response to preoperative treatment. Most surgery for gastroesophageal junction tumors can be performed minimally invasively, which helps decrease postoperative length of stay and morbidity from surgery.

AB - Gastroesophageal junction tumors have been increasing in incidence over time, with most tumors presenting at a locally advanced stage. The treatment plan depends on the stage at diagnosis. PET-CT and endoscopic ultrasound are used to determine clinical stage. Depending on the location of the tumor in the esophagus and stomach, treatment can include chemotherapy with or without radiation, followed by surgery if there is no disease progression. Prognosis is related to stage at diagnosis and response to preoperative treatment. Most surgery for gastroesophageal junction tumors can be performed minimally invasively, which helps decrease postoperative length of stay and morbidity from surgery.

KW - Adenocarcinoma

KW - Barrett

KW - Minimally invasive

KW - Neoadjuvant

UR - http://www.scopus.com/inward/record.url?scp=85012920084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012920084&partnerID=8YFLogxK

U2 - 10.1016/j.suc.2016.11.004

DO - 10.1016/j.suc.2016.11.004

M3 - Review article

C2 - 28325186

AN - SCOPUS:85012920084

VL - 97

SP - 265

EP - 275

JO - Surgical Clinics of North America

JF - Surgical Clinics of North America

SN - 0039-6109

IS - 2

ER -